Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-16

Clinical Trial Update: Performance and Safety of HyalganBio® Intra-Articular Injections as Add-On to Physical Exercise for Symptomatic Glenohumeral Osteoarthritis [NA]

View source ↗

Summary

An update on a clinical trial evaluating HyalganBio intra-articular injections added to exercise for symptomatic glenohumeral osteoarthritis, focusing on perfor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HyalganBio (sodium hyaluronate)

Snippet

Sponsor: Fidia Farmaceutici s.p.a. | Conditions: Glenohumeral Osteoarthritis | NA | Status: ACTIVE_NOT_RECRUITING